←Back to list

PathAI

Operator of an AI-powered research platform intended to improve the accuracy and efficiency of cancer diagnosis and trea
Laboratory Services (Healthcare) 📍 Boston, MA Founded 2016
Current Valuation
$1.0B
as of 2021-Q2
UNICORN
Operator of an AI-powered research platform intended to improve the accuracy and efficiency of cancer diagnosis and treatment.

Company Profile

Founded
2016
HQ
Boston, MA
Employees
268
Total Raised
$255M
Last Round
Series C — $165M (May 2021)
IPO Status
private

Fundraising Status

Series C · $165M · 5y 3mo ago
privateTotal raised $255M

Secondary Market

Implied price / share
$21.89
Last round price / share
$29.5
vs last round
-25.8%
Last round price vs secondary price
Last round vs current secondary price per share$29.50Last round$21.89Current
Secondary price return by period
Secondary market period returns3-month+0.5%6-month+1.2%1-year+1.3%All-time-25.8%
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →

Latest Funding Round

RoundAmountDateLead InvestorPost-Money
Series C$165MMay 2021—$1.0B
Health CareBiotechnologyHealth Diagnostics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q2. Refreshed quarterly.